Faculty of Science Charles University Prague 1 Czech Republic

General University Hospital Prague 1 Czech Republic

Institute of Animal Physiology and Genetics Czech Academy of Science PIGMOD Centre Libechov Czech Republic

Institute of Biotechnology Czech Academy of Sciences Prague West Czech Republic

Institute of Molecular Genetics Czech Academy of Sciences Prague 4 Czech Republic

Institute of Physiology Czech Academy of Sciences Prague 4 Czech Republic

School of Pharmacy and Medical Science Griffith University Southport Qld Australia

Zobrazit více v PubMed

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209‐249. PubMed

Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883‐892. PubMed PMC

Neuzil J, Dong LF, Rohlena J, et al. Classification of mitocans, anti‐cancer drugs acting on mitochondria. Mitochondrion. 2013;13(3):199‐208. PubMed

Smith RA, Hartley RC, Cochemé HM, Murphy MP. Mitochondrial pharmacology. Trends Pharmacol Sci. 2012;33(6):341‐352. PubMed

Rohlenova K, Schaphibulkij K, Stursa J, et al. Selective disruption of respiratory supercomplexes as a new strategy to suppress Her2high breast cancer. Antiox Redox Signal. 2017;26(2):84‐103. PubMed PMC

Modica‐Napolitano JS, Aprille JR. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv Drug Deliv Rev. 2001;49(1‐2):63‐70. PubMed

Isono T, Chano T, Yonese J, Yuasa T. Therapeutic inhibition of mitochondrial function induces cell death in starvation‐resistant renal cell carcinomas. Sci Rep. 2016;6:25669. PubMed PMC

Bajzikova M, Kovarova J, Coelho A, et al. Reactivation of dihydroorotate dehydrogenase by respiration restores tumor growth of mitochondrial DNA‐depleted cancer cells. Cell Metab. 2019;29(2):399‐416. PubMed PMC

Motzer RJ, Rini BI, McDermott DF, et al. Nivolumab for metastatic renal cell carcinoma: results of a randomized phase II trial. J Clin Oncol. 2015;33(13):1430‐1437. PubMed PMC

Kim S, Jang JY, Koh J, et al. Programmed cell death ligand‐1‐mediated enhancement of hexokinase 2 expression is inversely related to T‐cell effector gene expression in non‐small‐cell lung cancer. J Exp Clin Cancer Res. 2019;38(1):462. PubMed PMC

Chelation of Mitochondrial Iron as an Antiparasitic Strategy

Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial

MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115-126

Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial

Effects of metabolic cancer therapy on tumor microenvironment

Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens

Zobrazit více v PubMed

EudraCT
EudraCT 2017-004441-25